$65.72
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. The company is headquartered in Wilmington, Delaware and currently employs 2,900 full-time employees. The firm serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company’s segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.
Country

US

CEO

Mr. Guillermo Novo

IPO date

1980

Employees

2,900

ISIN

US0441861046

Key stats

Open

$63.71

Volume

634.24K

Market cap

$2.92B

Prev. close

$65.00

Impl / hst vl

-

Open interest

$0.00

$63.38

Day’s Range

$65.72

$48.19

52W Range

$68.26

Valuation

38
Valuation score
Overvalued
P/E
-
P/S
1.61
P/B
1.57
Current ratio
3.06
Debt / Equity
0.55
ROE
-37.52%
Gross margin
32.57%
Income growth
-233.33%
FCF growth
-74.74

Jun

15

Dividends

The last payment date was Jun 15, 2026

Div. per Share

$0.42

Div. Yield

0.66%

Payout Ratio

-

Div. Growth YoY

1.20%

Analysts estimates

Consensus rating
Buy

The average rating from top 8 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$70.22
The top 13 analysts forecasts that 12-month price may increase by 6.85%, with a low of $50.50 and a high of $94.50
$50.50
Low
$70.22
Avg
$94.50
High
Current price

Earnings

Q1 ‘26 revenue
$482.00M
Q1 ‘26 net income
$16.00M
Revenue
Net income
Previous EPS
$0.91
Estimate EPS
$1.03
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply